Delivery Order SPE2DR25D7066-SPE2DR26F7ZFV
- Not listed
- The Defense Logistics Agency awarded a $3,419.13 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award carries no set-aside designation and reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,700.77. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a non-competitive basis as part of a broader procurement relationship between DLA and the...
- The Defense Logistics Agency awarded a $12,517.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml units). The contract, awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. This award involved no set-aside designation and was competitively awarded. The...
- The Defense Logistics Agency awarded a $3,003.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injectors (0.5 mL dosage). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $15,344.90. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with a contract value of $2,252.25. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by November 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,501.50. This firm fixed price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 25, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZFVDelivery Order
The Defense Logistics Agency awarded a $5,814.80 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injectors (0.5 mL). The contract is a firm fixed price delivery order with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) running through December 2026, which serves as the prime vehicle enabling the company to supply pharmaceutical products and medical supplies to military healthcare systems worldwide. This delivery order for Trulicity, a diabetes medication, falls within the broader scope of AmerisourceBergen's comprehensive pharmaceutical support portfolio for the Defense Health Agency and other federal healthcare entities. The company's federal contract awards consistently demonstrate its capability to fulfill competitive medical supply requirements across multiple therapeutic domains through firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 11/20/25 |